Published in Radiat Oncol on November 29, 2006
Evaluation of heterogeneity dose distributions for Stereotactic Radiotherapy (SRT): comparison of commercially available Monte Carlo dose calculation with other algorithms. Radiat Oncol (2012) 0.92
Monte Carlo vs. pencil beam based optimization of stereotactic lung IMRT. Radiat Oncol (2009) 0.92
Stereotactic radiotherapy of intrapulmonary lesions: comparison of different dose calculation algorithms for Oncentra MasterPlan®. Radiat Oncol (2015) 0.81
A dosimetric phantom study of dose accuracy and build-up effects using IMRT and RapidArc in stereotactic irradiation of lung tumours. Radiat Oncol (2012) 0.80
Dosimetric evaluation of the impacts of different heterogeneity correction algorithms on target doses in stereotactic body radiation therapy for lung tumors. J Radiat Res (2012) 0.78
Stereotactic body radiotherapy for small lung tumors in the University of Tokyo Hospital. Biomed Res Int (2014) 0.78
Clinical relevance of different dose calculation strategies for mediastinal IMRT in Hodgkin's disease. Strahlenther Onkol (2012) 0.77
A clinical study of lung cancer dose calculation accuracy with Monte Carlo simulation. Radiat Oncol (2014) 0.77
Precise radiochromic film dosimetry using a flat-bed document scanner. Med Phys (2005) 2.63
Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer. Chest (2003) 2.60
Collapsed cone convolution of radiant energy for photon dose calculation in heterogeneous media. Med Phys (1989) 2.16
Fast Monte Carlo dose calculation for photon beams based on the VMC electron algorithm. Med Phys (1999) 1.57
Dose calculations for external photon beams in radiotherapy. Phys Med Biol (1999) 1.54
A pencil beam model for photon dose calculation. Med Phys (1992) 1.39
Post-irradiation colouration of Gafchromic EBT radiochromic film. Phys Med Biol (2005) 1.38
Weak energy dependence of EBT gafchromic film dose response in the 50 kVp-10 MVp X-ray range. Appl Radiat Isot (2005) 1.26
Stereotactic single-dose radiotherapy of stage I non-small-cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys (2003) 1.18
Experimental verification of convolution/superposition photon dose calculations for radiotherapy treatment planning. Phys Med Biol (2003) 1.15
A virtual photon energy fluence model for Monte Carlo dose calculation. Med Phys (2003) 1.10
Influence of calculation model on dose distribution in stereotactic radiotherapy for pulmonary targets. Int J Radiat Oncol Biol Phys (2005) 1.07
Characterization and real-time optical measurements of the ionizing radiation dose response for a new radiochromic medium. Med Phys (2005) 1.05
Impact of target reproducibility on tumor dose in stereotactic radiotherapy of targets in the lung and liver. Radiother Oncol (2003) 1.01
Limitations of a pencil beam approach to photon dose calculations in lung tissue. Phys Med Biol (1995) 0.98
Absorption spectra variations of EBT radiochromic film from radiation exposure. Phys Med Biol (2005) 0.96
Dose calculation accuracy of lung planning with a commercial IMRT treatment planning system. J Appl Clin Med Phys (2003) 0.88
Influence of calculation algorithm on dose distribution in irradiation of non-small cell lung cancer (NSCLC) collapsed cone versus pencil beam. Strahlenther Onkol (2004) 0.87
EGSNRC Monte Carlo study of the effect of photon energy and field margin in phantoms simulating small lung lesions. Med Phys (2003) 0.83
Verification of lung dose in an anthropomorphic phantom calculated by the collapsed cone convolution method. Phys Med Biol (2000) 0.83
Verification of dose calculations with a clinical treatment planning system based on a point kernel dose engine. J Appl Clin Med Phys (2002) 0.79
Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial. Lancet Oncol (2012) 2.97
Intraoperative radiotherapy for breast cancer. Lancet Oncol (2004) 2.91
Patient study of in vivo verification of beam delivery and range, using positron emission tomography and computed tomography imaging after proton therapy. Int J Radiat Oncol Biol Phys (2007) 2.33
Volumetric modulated arc therapy (VMAT) vs. serial tomotherapy, step-and-shoot IMRT and 3D-conformal RT for treatment of prostate cancer. Radiother Oncol (2009) 2.21
Real-time fMRI of temporolimbic regions detects amygdala activation during single-trial self-induced sadness. Neuroimage (2003) 2.09
Use of 111in-capromab pendetide immunoscintigraphy to image localized prostate cancer foci within the prostate gland. J Urol (2009) 2.03
Memory function before and after whole brain radiotherapy in patients with and without brain metastases. Int J Radiat Oncol Biol Phys (2008) 1.94
TARGeted Intraoperative radiotherapy (TARGIT): an innovative approach to partial-breast irradiation. Semin Radiat Oncol (2005) 1.83
Phase I trial of capecitabine and weekly irinotecan in combination with radiotherapy for neoadjuvant therapy of rectal cancer. J Clin Oncol (2005) 1.82
Development and optimization of a real-time quantitative PCR-based method for the titration of AAV-2 vector stocks. Mol Ther (2002) 1.75
Plerixafor inhibits chemotaxis toward SDF-1 and CXCR4-mediated stroma contact in a dose-dependent manner resulting in increased susceptibility of BCR-ABL+ cell to Imatinib and Nilotinib. Leuk Lymphoma (2009) 1.61
Intraoperative radiotherapy (IORT) for breast cancer using the Intrabeam system. Tumori (2005) 1.60
Genetic predictors of long-term toxicities after radiation therapy for breast cancer. Int J Cancer (2008) 1.58
Clinical consequences of PKHD1 mutations in 164 patients with autosomal-recessive polycystic kidney disease (ARPKD). Kidney Int (2005) 1.55
Neuregulin 1 ICE-single nucleotide polymorphism in first episode schizophrenia correlates with cerebral activation in fronto-temporal areas. Eur Arch Psychiatry Clin Neurosci (2008) 1.55
Tumor-platelet interaction in solid tumors. Int J Cancer (2012) 1.54
Sphere of equivalence--a novel target volume concept for intraoperative radiotherapy using low-energy X rays. Int J Radiat Oncol Biol Phys (2008) 1.53
Gender differences in the cognitive control of emotion: An fMRI study. Neuropsychologia (2007) 1.44
Characterization of human mesothelioma cell lines as tumor models for suicide gene therapy. Onkologie (2008) 1.44
kV cone-beam CT-based IGRT: a clinical review. Strahlenther Onkol (2011) 1.44
In vivo micro-CT imaging of untreated and irradiated orthotopic glioblastoma xenografts in mice: capabilities, limitations and a comparison with bioluminescence imaging. J Neurooncol (2015) 1.43
Multidimensional assessment of empathic abilities: neural correlates and gender differences. Psychoneuroendocrinology (2010) 1.41
PKHD1 mutations in autosomal recessive polycystic kidney disease (ARPKD). Hum Mutat (2004) 1.40
[Evidence-based treatment of depression: what does the new S3- and national healthcare guideline Unipolar Depression really recommend?]. Z Psychosom Med Psychother (2010) 1.40
Brain structure anomalies in autism spectrum disorder--a meta-analysis of VBM studies using anatomic likelihood estimation. Hum Brain Mapp (2011) 1.39
Predictive factors for late normal tissue complications following radiotherapy for breast cancer. Breast Cancer Res Treat (2007) 1.36
Predicting delirium after vascular surgery: a model based on pre- and intraoperative data. Ann Surg (2003) 1.33
Same or different? Neural correlates of happy and sad mood in healthy males. Neuroimage (2005) 1.30
Assessment of focal liver reaction by multiphasic CT after stereotactic single-dose radiotherapy of liver tumors. Int J Radiat Oncol Biol Phys (2003) 1.27
Potential effect of robust and simple IMRT approach for left-sided breast cancer on cardiac mortality. Int J Radiat Oncol Biol Phys (2008) 1.27
Association between polymorphisms in the DNA repair genes, XRCC1, APE1, and XPD and acute side effects of radiotherapy in breast cancer patients. Clin Cancer Res (2005) 1.26
Deformation field morphometry reveals age-related structural differences between the brains of adults up to 51 years. J Neurosci (2008) 1.25
The cytological features of mammary analogue secretory carcinoma: a series of 6 molecularly confirmed cases. Cancer Cytopathol (2012) 1.24
Genetic load on amygdala hypofunction during sadness in nonaffected brothers of schizophrenia patients. Am J Psychiatry (2004) 1.24
Long-term results of targeted intraoperative radiotherapy (Targit) boost during breast-conserving surgery. Int J Radiat Oncol Biol Phys (2010) 1.24
DEGRO Practical Guidelines for palliative radiotherapy of breast cancer patients: brain metastases and leptomeningeal carcinomatosis. Strahlenther Onkol (2010) 1.21
Tracer kinetic modelling of tumour angiogenesis based on dynamic contrast-enhanced CT and MRI measurements. Eur J Nucl Med Mol Imaging (2010) 1.21
Maintenance treatment with risperidone or low-dose haloperidol in first-episode schizophrenia: 1-year results of a randomized controlled trial within the German Research Network on Schizophrenia. J Clin Psychiatry (2007) 1.19
Generalized deficit in all core components of empathy in schizophrenia. Schizophr Res (2008) 1.19
IMRT for postoperative treatment of gastric cancer: covering large target volumes in the upper abdomen: a comparison of a step-and-shoot and an arc therapy approach. Int J Radiat Oncol Biol Phys (2004) 1.19
Repositioning accuracy of two different mask systems-3D revisited: comparison using true 3D/3D matching with cone-beam CT. Int J Radiat Oncol Biol Phys (2006) 1.16
Profiling of Candida albicans gene expression during intra-abdominal candidiasis identifies biologic processes involved in pathogenesis. J Infect Dis (2013) 1.16
Increased neural response related to neutral faces in individuals at risk for psychosis. Neuroimage (2007) 1.15
White-matter abnormalities in Tourette syndrome extend beyond motor pathways. Neuroimage (2010) 1.14
Intraoperative radiotherapy (IORT) is an option for patients with localized breast recurrences after previous external-beam radiotherapy. BMC Cancer (2007) 1.14
Neural correlates of emotion recognition in schizophrenia. Schizophr Res (2010) 1.14
Ischemic heart disease after breast cancer radiotherapy. N Engl J Med (2013) 1.11
Automated quality assurance routines for fMRI data applied to a multicenter study. Hum Brain Mapp (2005) 1.11
DEGRO practice guidelines for palliative radiotherapy of metastatic breast cancer: bone metastases and metastatic spinal cord compression (MSCC). Strahlenther Onkol (2009) 1.10
Continuous low-dose chemotherapy plus inhibition of cyclooxygenase-2 as an antiangiogenic therapy of glioblastoma multiforme. J Cancer Res Clin Oncol (2004) 1.10
Delusion of pregnancy. A case report and review of the literature. Psychopathology (2003) 1.08
Phantom and in-vivo measurements of dose exposure by image-guided radiotherapy (IGRT): MV portal images vs. kV portal images vs. cone-beam CT. Radiother Oncol (2007) 1.07
Neuronal correlates of facial emotion discrimination in early onset schizophrenia. Neuropsychopharmacology (2008) 1.07
Incongruence effects in crossmodal emotional integration. Neuroimage (2010) 1.07
PKHD1 mutations in families requesting prenatal diagnosis for autosomal recessive polycystic kidney disease (ARPKD). Hum Mutat (2004) 1.06
Stability of emotional dysfunctions? A long-term fMRI study in first-episode schizophrenia. J Psychiatr Res (2007) 1.06
Intraoperative radiotherapy as accelerated partial breast irradiation for early breast cancer : beware of one-stop shops? Strahlenther Onkol (2010) 1.06
DEGRO practical guidelines for radiotherapy of breast cancer I: breast-conserving therapy. Strahlenther Onkol (2007) 1.05
Radiation-related quality of life parameters after targeted intraoperative radiotherapy versus whole breast radiotherapy in patients with breast cancer: results from the randomized phase III trial TARGIT-A. Radiat Oncol (2013) 1.05
Can the risk of secondary cancer induction after breast conserving therapy be reduced using intraoperative radiotherapy (IORT) with low-energy x-rays? Radiat Oncol (2011) 1.05
Personal characteristics, therapy modalities and individual DNA repair capacity as predictive factors of acute skin toxicity in an unselected cohort of breast cancer patients receiving radiotherapy. Radiother Oncol (2003) 1.05
Late radiation toxicity after intraoperative radiotherapy (IORT) for breast cancer: results from the randomized phase III trial TARGIT A. Breast Cancer Res Treat (2012) 1.04
Assessment of brain metastases with dynamic susceptibility-weighted contrast-enhanced MR imaging: initial results. Radiology (2003) 1.04
Notification of critical results: a College of American Pathologists Q-Probes study of 121 institutions. Arch Pathol Lab Med (2008) 1.03
Differential brain activation during facial emotion discrimination in first-episode schizophrenia. J Psychiatr Res (2008) 1.03
Performance of an atlas-based autosegmentation software for delineation of target volumes for radiotherapy of breast and anorectal cancer. Radiother Oncol (2011) 1.02
A fast radiotherapy paradigm for anal cancer with volumetric modulated arc therapy (VMAT). Radiat Oncol (2009) 1.02
Single-center long-term follow-up after intraoperative radiotherapy as a boost during breast-conserving surgery using low-kilovoltage x-rays. Ann Surg Oncol (2010) 1.01
Genetic predictors of acute toxicities related to radiation therapy following lumpectomy for breast cancer: a case-series study. Breast Cancer Res (2006) 1.01
KRAS and BRAF mutations and PTEN expression do not predict efficacy of cetuximab-based chemoradiotherapy in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys (2010) 1.01
Radiobiological aspects of intraoperative radiotherapy (IORT) with isotropic low-energy X rays for early-stage breast cancer. Radiat Res (2005) 1.00
Radiation-induced DNA damage and repair in lymphocytes from breast cancer patients and their correlation with acute skin reactions to radiotherapy. Int J Radiat Oncol Biol Phys (2003) 1.00
Heart rate variability and spontaneous baroreflex sequences in supine healthy volunteers subjected to nasal positive airway pressure. J Appl Physiol (1985) (2005) 1.00
Long-term toxicity of an intraoperative radiotherapy boost using low energy X-rays during breast-conserving surgery. Int J Radiat Oncol Biol Phys (2006) 0.99
Unipolar depression: diagnostic and therapeutic recommendations from the current S3/National Clinical Practice Guideline. Dtsch Arztebl Int (2010) 0.99
Deep brain stimulation in the nucleus accumbens for intractable Tourette's syndrome: follow-up report of 36 months. Biol Psychiatry (2008) 0.99
Estimation of intracranial failure risk following hippocampal-sparing whole brain radiotherapy. Radiother Oncol (2013) 0.99
DEGRO practical guidelines for radiotherapy of breast cancer II. Postmastectomy radiotherapy, irradiation of regional lymphatics, and treatment of locally advanced disease. Strahlenther Onkol (2008) 0.99
A combination of granulocyte-colony-stimulating factor (G-CSF) and plerixafor mobilizes more primitive peripheral blood progenitor cells than G-CSF alone: results of a European phase II study. Cytotherapy (2009) 0.99
Cerebral dysfunctions of emotion-cognition interactions in adolescent-onset schizophrenia. J Am Acad Child Adolesc Psychiatry (2008) 0.98
Algorithm for efficient PKHD1 mutation screening in autosomal recessive polycystic kidney disease (ARPKD). Hum Mutat (2005) 0.98
A new strategy for online adaptive prostate radiotherapy based on cone-beam CT. Z Med Phys (2009) 0.98
[Report of the DGPPN 11/2009]. Nervenarzt (2009) 0.98
Neuropsychological outcome after fractionated stereotactic radiotherapy (FSRT) for base of skull meningiomas: a prospective 1-year follow-up. Radiother Oncol (2003) 0.97
Training of affect recognition in schizophrenia: Neurobiological correlates. Soc Neurosci (2009) 0.97
Phase I trial of cetuximab in combination with capecitabine, weekly irinotecan, and radiotherapy as neoadjuvant therapy for rectal cancer. Int J Radiat Oncol Biol Phys (2006) 0.97
Intraoperative radiotherapy (IORT) as a boost in patients with early-stage breast cancer -- acute toxicity. Onkologie (2006) 0.97
Long-term adjuvant administration of temozolomide in patients with glioblastoma multiforme: experience of a single institution. J Cancer Res Clin Oncol (2010) 0.96